Research reveals men skipping prostate cancer screenings are 45% more likely to die from the disease. Evidence from a large European study indicates P ...

PET/CT scans using an experimental prostate-specific membrane antigen (PSMA) imaging agent can identify SC nodal metastasis ...

Short-term ADT especially benefitted patients with a baseline PSA level of more than 2 ng/mL, a PSA doubling time of less than 3 months, and a higher metastatic stage, presumably because they were ...

Metastasis-suppressor genes are identified ... model systems might predict clinical efficacy more accurately. For most cancer cell types, the acquisition of metastatic ability leads to clinically ...

A study led by UCLA investigators shows that artificial intelligence (AI) could play a key role in improving treatment outcomes for men with prostate cancer by helping physicians determine who is most ...

Patients with mCRPC prostate cancer have an elevated risk of fractures due to bone metastases and use of androgen receptor pathway inhibitors (ARPI).

Brazil's health regulators have approved Telix Pharmaceuticals' nuclear imaging agent for prostate cancer, Illucix.

PORT ST. LUCIE — Francisco Alvarez was back in Mets camp Wednesday following surgery to remove the fractured hamate bone in his left hand. And the catcher said he was frustrated that he would ...

and a positive family history of prostate cancer. He presented to the accident and emergency department with urinary retention and renal impairment. Imaging (CT of the abdomen and pelvis) revealed ...

Some malignancies have acquired significant progress with the use of cancer vaccines, immune checkpoint inhibitors, and adoptive cells therapy. Scholars are exploring the aforementioned methods as ...

Materials and method: A total of 144 patients with prostate cancer who underwent preoperative MRI (T2WI and DWI) were retrospectively included. All patients were categorized into two groups based on ...